Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cuvitru in COPD with Humoral Deficiency
NCT05764993Phase 2Recruiting
- Sponsor
- Rochester General Hospital
- Start
- Jun 2023
- Primary completion
- Feb 2025
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of polyvalent human immunoglobulin in humoral immunodeficiency, sponsored by Rochester General Hospital. Started Jun 2023; status: recruiting.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
humoral immunodeficiency
Beyond the preview
Go deeper on NCT05764993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05764993.